Choose language:
About us Products Manufacturing Investor Relations Announcements 2008 2007 2006 2005 2004 2003 Annual General Meeting 2008 Share Price Key Figures Financial Calendar Annual & Interim Reports Shareholder Information Investment Calculator Presentations Conference call Analyst Coverage IR Policy Articles of Association Guidelines for Incentive Pay Corporate Governance Contact Media Join Us		Announcements for the Copenhagen Stock Exchange in 2003 17 December 2003 (No. 25-03) Bavarian Nordic A/S – Issues Financial Calendar for 2004 and Offers New Warrant Programme 2 December 2003 (No. 24-03) Bavarian Nordic invests DKK 250 million in vaccine production in North Zealand, Denmark 30 October 2003 (No. 23-03) Bavarian Nordic and Pharmexa join forces to develop new breast cancer vaccine 28 October 2003 (No. 22-03) Bavarian Nordic A/S – Third Quarterly Report as of 30 September 2003 1 October 2003 (No. 21-03) Bavarian Nordic A/S – Quarterly statement of Share ownership 25 September 2003 (No. 20-03) US Government grants additional award to Bavarian Nordic for development of MVA-BN as safe smallpox vaccine 26 August 2003 (No. 19-03) Bavarian Nordic A/S Interim Report as of 30 June 2003 1 July 2003 (No. 18-03) Bavarian Nordic A/S – Quarterly statement of Share ownership 16 June 2003 (No. 17-03) Bavarian Nordic A/S – Manufactures and releases MVA-BN doses two months ahead of schedule to US government 4 June 2003 (No. 16-03) Bavarian Nordic A/S - Revised financial calendar 27 May 2003 (No. 15-03) Bavarian Nordic A/S strengthening management team 13 May 2003 (No. 14-03) Bavarian Nordic A/S Accelerates MVA-BN Technical Development and Production Upscaling 7 May 2003 (No. 12-03) Bavarian Nordic A/S - Current statement of shareholdings 7 May 2003 (No. 13-03) Bavarian Nordic A/S – Complaint against vaccine contract in Germany rejected 29 April 2003 (No. 10-03) Bavarian Nordic A/S – Revised First Quarterly Report as of 31 March 2003 29 April 2003 (No. 09-03) Bavarian Nordic A/S - First Quarterly Report as of 31 March 2003 29 April 2003 (No. 11-03) Bavarian Nordic A/S – Report on Ordinary General Meeting 29 April 2003 1 April 2003 (No. 08-03) Bavarian Nordic A/S – Quarterly statement of Share ownership 6 March 2003 (No. 07-03) Bavarian Nordic A/S – Annual Report 2002 5 March 2003 (No. 06-03) Bavarian Nordic’s MVA-BN vectored HIV Vaccine Candidate Shows Promising Data In HIV-Infected Patients 26 February 2003 (No. 05-03) Bavarian Nordic initiates Phase II of the clinical development of MVA-BN as a safe smallpox vaccine 25 February 2003 (No. 04-03) Bavarian Nordic and the US Department of Health and Human Services (HHS) sign contract for development of MVA-BN as a safe smallpox vaccine for the US 7 February 2003 (No. 03-03) Bavarian Nordic wins its largest contract for supply of smallpox vaccines ever 2 January 2003 (No. 02-03) Bavarian Nordic A/S – Quarterly Statement of Share Ownership 2 January 2003 (No. 01-03) Bavarian Nordic A/S – Financial calendar 2003
Home | Sitemap | Disclaimer | Privacy Contact us